KCNH2 and familial dilated cardiomyopathy: In practice, Liang et al. demonstrated that healthy and diseased individuals, such as patients with LQT, HCM, and DCM, exhibit differential susceptibility to cisapride, a hERG blocker, and efficiency of CTiDs compared with results for the conventional hERG test (Liang et al., 2013).